AWAK Attracts Investment Billions

Singapore-based AWAK Technologies’ miniaturized sorbent platform for PD and HD regenerates dialysate to use up to 90% less fluid. This package was intriguing enough to attract an $11.2B investment from Accuron MedTech—improving its changes of reaching the market!

Read the full article » | Posted 06-12-2017

Related Articles

• 3D Print A New Kidney? Posted 08-11-2022
• Progress in Wearable and Implantable Kidneys Posted 08-11-2022
• Medical Device Transforms Fluid Removal in Kidney Care Posted 07-13-2022
• Phraxis, Inc Seeking FDA 510(k) Clearance for InterGraft Posted 05-12-2022